Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iMany was a prominent provider of contract performance, pricing, and revenue management software solutions specifically designed for the life sciences industry. The company's platform enabled pharmaceutical, biotech, and medical device manufacturers to manage complex rebate structures, government pricing compliance, and gross-to-net accounting. By automating these critical financial processes, iMany helped organizations minimize revenue leakage and maintain regulatory compliance with programs like Medicaid and Medicare. The company served a significant portion of the top global pharmaceutical companies, establishing itself as a leader in the healthcare IT sector. Following its acquisition by LLR Partners and subsequent merger, the company was rebranded as Revitas in 2012 and was eventually acquired by Model N in 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iMany.